Effect of Adenosine Monophosphate Deaminase-1 C34T Allele on the Requirement for Donor Inotropic Support and on the Incidence of Early Graft Dysfunction After Cardiac Transplantation

American Journal of Cardiology

Volumn 103, Issue 10, 2009, Pages 1457-1462

  Taegtmeyer, Anne B ^a,b   Breen, Jane B ^a   Rogers, Paula ^a   Johnson, Philip H ^b   Smith, John ^a   Smolenski, Ryzard T ^b   Banner, Nicholas R ^a,b   Yacoub, Magdi H ^b   Barton, Paul J ^b  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; INOTROPIC AGENT;

ADOLESCENT; ADULT; AGED; ALLELE; AMPD1 GENE; ANEMIA; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENOTYPE; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; AMP DEAMINASE; ANEMIA; BRAIN DEATH; CARDIOTONIC AGENTS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TISSUE DONORS;

EID: 65449138687     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.01.360     Document Type: Article

References (23)

1. Yacoub M.H., Yuen A.H., Kalsi K.K., Birks E.J., Taegtmeyer A.B., Barton P.J., Johnson P.H., Suzuki K., and Smolenski R.T. C34T AMP deaminase 1 gene mutation protects cardiac function in donors. Transplantation 77 (2004) 1621-1623
2. Yuen A.H., Yacoub M.H., Birks E.J., Kalsi K.K., Johnson P.H., and Smolenski R.T. Association of improved cardiac function in donors with C34T mutation of the AMP deaminase 1 gene. Nucleosides Nucleotides Nucleic Acids 24 (2005) 275-277
3. Bleasdale R.A., Banner N.R., Anyanwu A.C., Mitchell A.G., Khaghani A., and Yacoub M.H. Determinants of outcome after heterotopic heart transplantation. J Heart Lung Transplant 21 (2002) 867-873
4. Boucek M.M., Faro A., Novick R.J., Bennett L.E., Fiol B., Keck B.M., and Hosenpud J.D. The registry of the International Society of Heart and Lung Transplantation: third official pediatric report-1999. J Heart Lung Transplant 18 (1999) 1151-1172
5. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Boucek M.M., and Novick R.J. The registry of the International Society for Heart and Lung Transplantation: sixteenth official report-1999. J Heart Lung Transplant 18 (1999) 611-626
6. Felkin L.E., Taegtmeyer A.B., and Barton P.J.R. Real time quantitative PCR in cardiac transplantation research. Methods Mol Biol 333 (2006) 305-330
7. Loh E., Rebbeck T.R., Mahoney D., Denofrio D., Swain J.L., and Holmes E.W. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 99 (1999) 1422-1425
8. Anderson J.L., Habashi J., Carlquist J.F., Muhlestein J.B., Horne B.D., Bair T.L., Pearson R.R., and Hart N. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J Am Coll Cardiol 36 (2000) 1248-1252
9. Taegtmeyer A.B., Rogers P., Breen J., Barton P.J., Banner N.R., and Yacoub M. The effects of pre and post transplant anemia on one year survival after cardiac transplantation. J Heart Lung Transplant 27 (2008) 394-399
10. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Aurora P., Christie J., Dobbels F., Rahmel A.O., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
11. Zaroff J.G., Babcock W.D., and Shiboski S.C. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant 22 (2003) 334-337
12. Yazaki Y., Muhlestain J.B., Carlquist J.F., Blair T.L., Harne B.D., Renlund D.G., and Anderson J.L. A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction. J Card Fail 10 (2004) 316-320
13. Kolek M.J., Carlquist J.F., Thaneemit-Chen S., Lazzeroni L.C., Whiting B.M., Horne B.D., Muhlestein J.B., Lavori P., and Anderson J.L. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure. J Card Fail 11 (2005) 677-683
14. Shryock J.C., and Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79 (1997) 2-10
15. Gastmann A., Sigusch H.H., Henke A., Reinhardt D., Surber R., Gastmann O., and Figulla H.R. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome). Am J Cardiol 93 (2004) 1260-1264
16. Zhu Q., Yang X., Claydon M.A., Hicks Jr. G.L., and Want T. Adenosine deaminase inhibitor in cardioplegia enhanced function preservation of the hypothermically stored rat heart. Transplantation 57 (1994) 35-40
17. Stoica S.C., Goddard M., and Large S.R. The endothelium in clinical cardiac transplantation. Ann Thorac Surg 73 (2002) 1002-1008
18. Smolenski R.T., Kochan Z., McDouall R., Page C., Seymour A.L., and Yacoub M.H. Endothelial nucleotide catabolism and adenosine production. Cardiovasc Res 28 (1994) 100-104
19. Picano E., De Pieri G., Salerno J.A., Arbustini E., Distante A., Martinelli L., Pucci A., Montemartini C., Viganò M., and Donato L. Electrocardiographic changes suggestive of myocardial ischemia elicited by dipyridamole infusion in acute rejection early after heart transplantation. Circulation 81 (1990) 72-77
20. Birks E.J., Owen V.J., Burton P.B., Bishop A.E., Banner N.R., Khaghani A., Polak J.M., and Yacoub M.H. Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 102 (2000) 326-331
21. Birks E.J., Burton P.B., Owen V., Mullen A.J., Hunt D., Banner N.R., Barton P.J., and Yacoub M.H. Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 102 suppl 3 (2000) III3 52-III3 58
22. Agewall S., and Norman B. Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease. Pathophysiol Haemost Thromb 35 (2006) 440-444
23. Chou T.M., Sudhir K., Amidon T.M., Klinski C.S., DeMarco T., Chatterjee K., and Botvinick E.H. Comparison of adenosine to dipyridamole in degree of coronary hyperemic response in heart transplant recipients. Am J Cardiol 78 (1996) 908-913